Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurora CannabisACB +2.24%57 EV-to-OCF is -10.72 as of Jul. 28, 2026. GuruFocus rates ACB with a GF Score™ of 57/100 and a GF Value™ of $4.20 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Aurora Cannabis ranks better than 82.14% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Aurora Cannabis's Enterprise Value is $103.4 Mil.
Aurora Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-9.6 Mil. Therefore, Aurora Cannabis's EV-to-OCF for today is -10.72.
The historical rank and industry rank for Aurora Cannabis's EV-to-OCF or its related term are showing as below:
ACB'
s EV-to-OCF Range Over the Past 10 Years
Min: -303.08 Med: -10.42 Max: 218.71
Current: -10.76
During the past 13 years, the highest EV-to-OCF of Aurora Cannabis was 218.71. The lowest was -303.08. And the median was -10.42.
ACB's EV-to-OCF is ranked better than 82.14% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.59
vs ACB: -10.76
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aurora Cannabis's PE Ratio (TTM) for today is calculated as:
Aurora Cannabis's share price for today is $2.74.
Aurora Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.556.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aurora Cannabis EV-to-OCF Related Terms
Aurora Cannabis EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Aurora Cannabis's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Cannabis EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Aurora Cannabis's EV-to-OCF falls into.
Aurora Cannabis's current Enterprise Value is $103.4 Mil.
Aurora Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Cannabis (ACB) has a EV-to-OCF of -10.72 as of Jul. 28, 2026. According to the industry distribution chart, Aurora Cannabis ranks #180 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 17.9%.
Is Aurora Cannabis' EV-to-OCF too high?
Aurora Cannabis' current EV-to-OCF is -10.72. Based on the distribution chart, Aurora Cannabis ranks #180 out of 1008 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Aurora Cannabis has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aurora Cannabis ranks #180 out of 1008 companies for EV-to-OCF. This places Aurora Cannabis in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 10.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.59, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Cannabis's current EV-to-OCF is -10.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.20, compared to a current price of $2.74 — trading 34.8% below its estimated fair value. The current EV-to-OCF is -10.72. Aurora Cannabis' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current EV-to-OCF is -10.72 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Cannabis (ACB) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued.
The current stock price of $2.74 is trading 34.8% below its estimated GF Value™ of $4.20.
GuruFocus considers Aurora Cannabis to be Possible Value Trap.
Key valuation signals for ACB:
EV-to-OCF: -10.72
GF Value™: $4.20 vs. price of $2.74 (34.8% below fair value)
No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
57GF Score
Get the complete analysis for ACB
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACB has been successfully added to your 
